M&A Deal Summary

Dechra Pharmaceuticals Acquires Eurovet Animal Health B.V.

On April 5, 2012, Dechra Pharmaceuticals acquired life science company Eurovet Animal Health B.V. from A.U.V. Holding B.V. for 135M EUR

Acquisition Highlights
  • This is Dechra Pharmaceuticals’ 6th transaction in the Life Science sector.
  • This is Dechra Pharmaceuticals’ 2nd largest (disclosed) transaction.
  • This is Dechra Pharmaceuticals’ 1st transaction in the Netherlands.

M&A Deal Summary

Date 2012-04-05
Target Eurovet Animal Health B.V.
Sector Life Science
Buyer(s) Dechra Pharmaceuticals
Sellers(s) A.U.V. Holding B.V.
Deal Type Divestiture
Deal Value 135M EUR

Target

Eurovet Animal Health B.V.

Bladel, Netherlands
Eurovet is a Continental European veterinary pharmaceuticals business based in the Netherlands, which operates in both the companion animal pharmaceuticals and farm animal pharmaceuticals markets.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Dechra Pharmaceuticals

Northwich, United Kingdom

Category Company
Founded 1997
Sector Life Science
Revenue 682M GBP (2022)
DESCRIPTION

Dechra Pharmaceuticals is an international specialist in veterinary pharmaceuticals and related products business. Its expertise is in the development, manufacturing, sales, and marketing of quality products exclusively for veterinarians worldwide. The company's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Dechra Pharmaceuticals was founded in 1997 and is based in Northwich, United Kingdom.


DEAL STATS #
Overall 7 of 16
Sector: Life Science M&A 6 of 14
Type: Divestiture M&A Deals 1 of 1
Country: Netherlands M&A 1 of 3
Year: 2012 M&A 2 of 2
Size (of disclosed) 2 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-01-31 Bexinc

Ontario, Canada

Bexinc Ltd. is a developer of HY-50 which is used for intra-articular ("IA") or intravenous ("IV") treatment of lameness in horses caused by joint dysfunction. It is unique in Europe as being the only single injection to deliver 50mg of Sodium Hyaluronate and having both IA and IV indications.

Buy CA$8M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-10 National Veterinary Services

Staffordshire, United Kingdom

National Veterinary Services Ltd., practices are seeing purchases of Diets and accessories move to internet pharmacy and more and more practices are structuring their business to emphasise the work done and services provided to deliver the majority of their revenue and profit.

Sell -

Seller(S) 1

SELLER

A.U.V. Holding B.V.

Cuijk, Netherlands

Category Company
Founded 1969
Sector Distribution
DESCRIPTION

AUV Group comprises a distribution business and a pharmaceutical business, as well as a majority stake in a pet insurance business and the holding company.


DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 2
Country: Netherlands M&A 1 of 2
Year: 2012 M&A 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-04-11 AUV Veterinary Services B.V.

Cuijk, Netherlands

AUV Veterinary Services is a distributor serving animal health practitioners in the Netherlands and Belgium.

Sell -